Recon: Amgen sues Samsung Bioepis over bone drug biosimilars; Carlyle to buy Baxter’s kidney care unit for $3.8B
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States